Hanall Biopharma Co., Ltd. (KOSE: A009420)
Health Care · Pharmaceuticals · KR
₩46,100.00
-1.07% today · +31.9% 1Y
Hanall Biopharma Co., Ltd. (KOSE: A009420) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.74B.
Over the last twelve months the share price has gained 31.9%, trading between 32.60K and 73.00K.
Tweenvest scores Hanall Biopharma Co., Ltd. across four factors: quality 74/100, value 44/100, growth 44/100. Its strongest factor is quality.
A009420 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.74B
- Revenue (TTM)
- $105.04M
- P/E
- —
- EPS
- -490.57
- Dividend yield
- —
- Beta (5Y)
- 0.93
- 52-week high
- ₩73,000.00
- 52-week low
- ₩32,600.00
- Avg volume (3M)
- —
- Shares outstanding
- 50.86M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Septerna, Inc.NasdaqGM: SEPN | $1.76B | $36.90 | -2.15% |
| Zhejiang Medicine Co., Ltd.SHSE: 600216 | $1.76B | CN¥12.43 | +0.81% |
| Alivus Life Sciences LimitedNSEI: ALIVUS | $1.75B | Rs1,374.20 | +0.63% |
| Tsumura & Co.TSE: 4540 | $1.75B | ¥3,703.00 | -4.51% |
| Eris Lifesciences LimitedNSEI: ERIS | $1.71B | Rs1,189.80 | -5.49% |
| Bora Pharmaceuticals Co., Ltd.TWSE: 6472 | $1.68B | NT$420.50 | -0.24% |
| Shanghai Shyndec Pharmaceutical Co., Ltd.SHSE: 600420 | $1.68B | CN¥8.39 | +2.07% |
| Alembic Pharmaceuticals LimitedNSEI: APLLTD | $1.66B | Rs815.25 | -5.62% |
Figures last refreshed Oct 4, 2026.